Artience (TSE:4634) On Fresh 2026 Guidance Looks Modestly Undervalued
Why artience issued fresh 2026 guidance
artience (TSE:4634) recently issued consolidated earnings guidance for the year ending December 31, 2026, outlining expected net sales, profits and earnings per share. The same day, its board met to consider an interim dividend.
See our latest analysis for artience.
The guidance update appears to have arrived during a strong run for artience, with a 1 month share price return of 18.27% and a year to date share price return of 46.38%. The 5 year total shareholder return of 200.81% points to substantial gains for longer term holders.
If this kind of momentum has you thinking about other ideas, it could be a good time to broaden your search and check out 11 top founder-led companies
Bulls point to artience's strong recent share price and fresh 2026 guidance. Bears focus on whether those expectations already sit in the ¥5,050 price. The next step is to see what the valuation numbers suggest.
Price to earnings of 12.7x for artience, is it justified?
On the latest figures, artience is trading on a P/E of 12.7x, which sits slightly below its estimated fair P/E of 13.4x and a touch above the wider JP Chemicals sector at 12.5x. That mix of readings suggests the current ¥5,050 price reflects a market view that is neither stretched nor distressed when set against earnings.
The P/E ratio compares artience's current share price to its earnings per share. It gives a simple snapshot of what investors are paying for each unit of profit. For a company with a long operating history and exposure to areas like colorants, polymers and packaging materials, earnings-based measures are often used as a core reference point because profit trends matter more than hyper growth narratives.
In artience's case, the current P/E of 12.7x sits below the estimated fair P/E of 13.4x. This implies the market is assigning a slightly lower multiple than the level the fair ratio model points to. Over the past five years, earnings have grown 14% per year, with a 26.9% rise over the last year and current net profit margins at 5% compared with 4.2% a year earlier. That track record of profit growth, combined with high quality earnings and an SWS DCF estimate of future cash flow value at ¥10,889.14 per share, indicates a gap between current pricing and what the model suggests the multiple could move towards over time.
Relative to the broader JP Chemicals industry, artience's 12.7x P/E is only slightly higher than the sector average of 12.5x. This points to the stock being priced in line with peers rather than at a steep premium. When that is compared with the fair P/E of 13.4x, the current market level looks conservative rather than aggressive. For investors, the key question is whether the recent growth in earnings and margins, along with the forecast earnings growth of 3.55% per year, justifies a P/E closer to that higher fair ratio level.
Explore the SWS fair ratio for artience
Result: Price to earnings of 12.7x (UNDERVALUED)
However, artience still faces risks if earnings or cash flows fall short of current assumptions, or if sector conditions in chemicals and packaging become less favourable.
Find out about the key risks to this artience narrative.
Another view on artience using the SWS DCF model
The earlier P/E work suggests artience looks modestly cheap. The SWS DCF model goes further. It places future cash flow value at ¥10,889.14 per share against the current ¥5,050 price, which flags the stock as materially undervalued on this framework.
For investors, that gap raises a simple question. Is the market correctly discounting execution and sector risks, or is there mispricing that might eventually close as cash flows play out in reported numbers. Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out artience for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 22 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
If this mix of guidance, valuation work and sentiment on artience leaves you unsure, you should review the underlying figures yourself and form your own view. To see what investors are optimistic about, review the 4 key rewards
Looking for more investment ideas beyond artience?
If artience has your attention, do not stop here. Use the Simply Wall Street Screener to quickly surface other opportunities that fit your style.
- Focus on stability and consistent cash strength by reviewing companies in the solid balance sheet and fundamentals stocks screener (41 results).
- Hunt for potential bargains that combine quality with pricing that still looks reasonable using the 22 high quality undervalued stocks.
- Target income focused opportunities that aim to balance yield with resilience through the 37 dividend fortresses.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com